In our study, monocyte counts with differential CD62L expression were strongly associated with specific cancers, and populations of neutrophil, T cell, NK cell and B cell subsets were dramatically altered in tumor-bearing animals; these were then used to train the ML model by the pipeline-identified leukocyte subset counts from as little as 5μl of blood. This evidence concerns the gene SELL and cancer.